- Report
- June 2024
- 200 Pages
Global
From €7133EUR$7,950USD£6,140GBP
- Report
- January 2022
- 60 Pages
Global
From €3544EUR$3,950USD£3,050GBP
Hydrocephalus is a medical condition in which cerebrospinal fluid accumulates in the brain, leading to increased intracranial pressure. Treatment of hydrocephalus typically involves the use of drugs to reduce the amount of cerebrospinal fluid in the brain. These drugs are classified as Central Nervous System (CNS) drugs, and are used to treat a variety of neurological conditions.
The hydrocephalus drug market is a subset of the CNS drug market, and includes drugs used to treat hydrocephalus. These drugs are typically used to reduce the amount of cerebrospinal fluid in the brain, and can be administered orally, intravenously, or through a shunt. Common drugs used to treat hydrocephalus include diuretics, anticonvulsants, and corticosteroids.
The hydrocephalus drug market is highly competitive, with many companies offering a variety of drugs to treat the condition. Some of the major companies in the market include Pfizer, Novartis, Merck, and GlaxoSmithKline. Show Less Read more